Loading candles…
Anuh Pharma Ltd, incorporated in 1960, operates primarily in the pharmaceuticals and chemicals industries. The company manufactures and sells bulk drugs and chemicals, with a particular focus on Active Pharmaceutical Ingredients (APIs) and related pharmaceutical products. Its business segments include Active Pharmaceutical Ingredients manufacturing, pharmaceutical formulations, trading, and logistics. Anuh Pharma holds a significant market position in Macrolides and Anti-TB products and is recognized as one of India's largest manufacturers in these categories. It offers a range of products such as bulk drugs, chemicals, Macrolides, Anti-TB, Anti-bacterial, Anti-malarial, Anti-hypertension, and Corticosteroid medicines. The company operates across multiple geographies including India, Europe, Africa, Asia, and the Americas, exporting to over 59 countries worldwide, with exports accounting for about 55% of its total revenue in FY25. Anuh Pharma is a member of the SK Group and is listed on the exchange under the symbol ANUHPHR.
| 8 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend, bonus and other business matters | 23 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.